openPR Logo
Press release

Increasing Awareness and Financial Support for Mental Health Drives the Global Substance Abuse Treatment Market Growth

10-06-2016 09:12 AM CET | Health & Medicine

Press release from: TMR - Research Reports

Increasing Awareness and Financial Support for Mental Health

There has been an increase in the use and abuse of the substances such as alcohol, drugs, and cigarettes. Substance abuse is defined as harmful use of these substances in order to alter the mood. Generally, substance abuse is referred to the use of illegal drugs as these are potentially addictive and can pose negative health effects.

However, alcohol, inhalants, solvents and even coffee can be abused. Hence, almost any substance can be used to a harmful extent and can be abused. Substance abuse results in health deterioration irrespective of addiction. Chaotic home environment, genetic risks, poor social coping skills and inappropriate behavior are some of the factors that may cause substance abuse. Early recognition of substance abuse symptoms can increase the chances of successful treatment.

Download Exclusive Sample of this Report: http://bit.ly/2dvLgXq

Aggressiveness, irritability and forgetfulness constitute substance abuse symptoms. Doctors recommend community resources for the patients willing to quit the substance abuse. During this process doctors may also prescribe certain medications that help control the cravings and manage the medical complications resulting from the substance abuse. As a part of education the patients are recommended to seek immediate medical care if they experience these symptoms.

Currently, with the increasing use of illicit drugs, leading to increased number of deaths and healthcare costs. For instance, in the United States, illicit drug prescription and alcohol abuse resulted in around more than 90,000 deaths while tobacco abuse results in around 480,000 deaths annually. Furthermore, management of increasing addiction and abuse to nicotine, alcohol and illicit prescription drugs costs around USD 700 billion for the Americans every year.

Several research studies identified that combination of behavioral therapy along with medications ensures best mode of treating the patients. This is necessary as long term use of drugs alters the brain function and enhances the compulsions to use the drugs. Hence, prevention of relapse is one of the most important components of substance abuse treatment.

Behavioral therapy enables the patient to cope up with the drug cravings and avoid relapse. Medications such as Methadone and nicotine patches assist in controlling the withdrawal symptoms and drug cravings. Medical treatment is necessary as drug users are observed to have an underlying medical disorder which must be treated along with the drug abuse treatment.

The market for substance abuse therapeutics can be segmented into alcohol, nicotine dependence therapeutics and drug abuse therapeutics. For instance, Chantix (vareniciline) and zyban represents the medications prescribed against nicotine addiction. In addition, Vivitrol (naltrexone), Campral (acamprosate calcium) and disulfrum are some of the drugs recommended for the patients suffering from alcohol dependence. Cocaine and opioid abuse are some of the drug abuse therapeutics.

Other factors such as annual cost of the treatment and regulatory policies govern the market growth. Geographically, developed economies such as the U.S., the U.K., Japan, Germany, France, Spain and others exhibit high number of substance abuse patients as compared to developing economies such as China and India.

The factors such as increased awareness and financial support for mental health and substance abuse treatment along with increasing substance abuse illness will drive the market growth. Furthermore, this factor favors the growth of mental and substance abuse centers.

Browse Research Report: http://bit.ly/2dztKAs

On the other hand factors such as no control over the addiction and lack of willingness to seek treatment for the substance abuse might restrain the market growth. Teva Pharmaceutical Industries, ltd., GlaxoSmithKline plc, Alkermes plc, Reckitt Benckiser Pharmaceuticals, Inc. and Pfizer, Inc. are some of the companies operating in this market.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Increasing Awareness and Financial Support for Mental Health Drives the Global Substance Abuse Treatment Market Growth here

News-ID: 370055 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Transparency

transparency market research
The global Custom Antibody Market market is estimated to attain a valuation of US$1 Billion by the end of 2033, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 0.085% during the forecast period, 2023 to 2033. The key objective of the TMR report is to offer a complete assessment of the global market including major leading
Transparency Market Research
A belt drive is a type of power transmission device which is a looped belt wound around a pair of pulley so as to transmit power between two or more rotating shafts. Compared to other power transmitting devices, belt drives are more preferred in mechanical industry due to easy installation, numerous speed ratio selections, less power loss and comparative low price. Belt drive protects the rotating machinery from overload fluctuations
Transparency Market Research
An ultrasonic motor is an electric motor which is driven by the ultrasonic vibration of a component. The stator of the motor is supported by piezoelectric components in ultrasonic frequency range which produces different types of vibrations depending on its arrangement. In other words, ultrasonic motor is a type of electric motor that transforms ultrasonic physical vibrations to linear motion, produced by a piezo-transducer. Ultrasonic motors therefore do not use
More transparency in Engineering IT
CPO certification helps evaluate openness of IT systems Digitalization is making openness in the linking of IT solutions increasingly important. The Code of PLM Openness (CPO), developed by the ProSTEP iViP Association, supplies a concrete approach for achieving precisely that. Fraunhofer IAO has now developed an effective certification for companies, which helps them comply with the CPO criteria. Industrie 4.0 requires intensified collaboration between various tools and systems. Only when
eDataCenterAnalyzer Increases Transparency in Data Centers
30 June 2016. Walldorf, Germany. – fluid Operations™ AG (fluidOps), a leader in semantic technologies, today launched eDataCenterAnalyzer™, an app that increases transparency in data centers. With the launch of this app and new releases of its Smart Data Platform Information Workbench™ and cloud management app eCloudManager™, the company has set the cornerstone for the future development of its product portfolio. eDataCenterAnalyzer combines the full functionality of Information Workbench with innovative
Transparency across the entire process chain
Leitner Spedition implements best4log-x • Austrian trucking company uses arvato Systems solution • End-to-end process management provides higher efficiency (arvato Systems) Gütersloh / Unterpremstätten – Since the beginning of 2015, the Austrian trucking company Leitner Spedition has been working with the best4log-x transport management system. This SAP-based solution from arvato Systems provides an integrated digital information flow and supports mid-sized companies in achieving a transparent process design. Controlling and Reporting have seen a